Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	96.65	94.82	224.95	71.66	171.33	168.13
Short-Term Investments	284.5	196.56	2.5	145.37	0.48	-
Cash & Short-Term Investments	381.14	291.38	227.44	217.03	171.82	168.13
Cash Growth	17.79%	28.11%	4.80%	26.31%	2.19%	190.12%
Accounts Receivable	58.33	46.76	16.62	-	-	-
Other Receivables	1.91	1.3	1.09	3.58	0.09	0.02
Receivables	60.24	48.06	17.71	3.58	0.09	0.02
Inventory	3.87	2.62	3.11	-	-	-
Prepaid Expenses	29.17	14.65	7.87	4.77	4.05	2.49
Restricted Cash	-	-	-	-	-	0.02
Total Current Assets	474.43	356.71	256.13	225.38	175.95	170.66
Property, Plant & Equipment	3.41	2.87	3.35	1.53	1.83	1.24
Long-Term Investments	3	3	0.86	0.48	0.66	-
Other Intangible Assets	7.85	8.33	3.87	-	-	-
Other Long-Term Assets	6.31	6.09	1.29	0.48	0.46	0.08
Total Assets	494.99	376.99	265.49	227.86	178.91	171.97
Accounts Payable	28.08	27.74	17.77	5.5	2.86	2.24
Accrued Expenses	16.74	19.14	13.9	9.21	7.26	2.87
Current Portion of Leases	0.32	0.61	0.4	0.72	0.61	0.28
Current Income Taxes Payable	-	-	-	-	0.06	-
Current Unearned Revenue	-	-	-	-	0.7	-
Other Current Liabilities	45.12	33.12	4.87	-	-	-
Total Current Liabilities	90.25	80.61	36.94	15.43	11.48	5.39
Long-Term Debt	72.13	71.85	29.82	19.43	-	-
Long-Term Leases	-	-	-	-	0.59	0.55
Other Long-Term Liabilities	-	-	1.75	0.1	0.11	0.06
Total Liabilities	162.38	152.46	68.5	34.96	12.18	5.99
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	738.24	584.56	441.64	301.73	213.4	198.82
Retained Earnings	-405.67	-360.21	-244.66	-108.76	-46.67	-32.85
Comprehensive Income & Other	0.04	0.18	-0	-0.07	-	-
Total Common Equity	332.61	224.53	196.99	192.9	166.73	165.98
Shareholders' Equity	332.61	224.53	196.99	192.9	166.73	165.98
Total Liabilities & Equity	494.99	376.99	265.49	227.86	178.91	171.97
Total Debt	72.45	72.45	30.22	20.16	1.19	0.83
Net Cash (Debt)	308.7	218.92	197.23	196.87	170.62	167.3
Net Cash Growth	23.50%	11.00%	0.18%	15.38%	1.99%	189.50%
Net Cash Per Share	7.76	5.82	6.71	8.00	8.30	26.95
Filing Date Shares Outstanding	42.21	38.38	34.22	26.73	20.71	20.32
Total Common Shares Outstanding	42.21	38.35	34.21	26.73	20.7	20.32
Working Capital	384.18	276.09	219.2	209.95	164.47	165.27
Book Value Per Share	7.88	5.85	5.76	7.22	8.06	8.17
Tangible Book Value	324.77	216.21	193.12	192.9	166.73	165.98
Tangible Book Value Per Share	7.69	5.64	5.64	7.22	8.06	8.17
Machinery	4.43	3.5	2.08	1.08	0.85	0.54
Leasehold Improvements	1.16	0.79	0.68	0.43	0.13	0.14

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q